Inclusion Criteria:  Patients with peripheral T-cell lymphoma confirmed by primary pathology; Age 18-70 years; ECOG performance status ≤ 2; Adequate bone marrow hematopoietic function: WBC > 3.5 × 10*9/L，ANC>1.5 × 10*9/L，HGB>90g/L，PLT>80 × 10*9/L; Adequate organ function: cardiac function grade 0-2 (NYHA); SpO2 > 88% (natural condition); ALT<3UNL，TBil<2ULN; SCr>60ml/min/m2; Patients have signed the Informed Consent Form  Exclusion Criteria:  ALK positive anaplastic T-cell lymphoma; NK / T cell lymphoma, nasal type; Uncontrolled active infection; Acute myocardial infarction or unstable angina pectoris within 6 months; uncontrolled hypertension, symptomatic arrhythmia, etc; Subjects who are known or suspected to be unable to comply with the study protocol; Pregnant or lactating women